[Therapy of chronic urticaria and recurrent Quincke edema].
A rational and differential therapy of chronic urticaria and relapsing angioedema must be based on a precise classification of the disease. The general management as well as the specific therapy will have to consider the various trigger factors involved, the differences in the response rates to antiallergic drugs and the different prognoses of the urticaria subforms. Therefore this article will first briefly describe the most frequent subforms of urticaria and relapsing angioedema, and then discuss their management and treatment.
Kündig
T M
TM
Dermatologische Klinik, Universitätsspital Zürich. tkuendig@derm.unizh.ch
D000799:Angioedema / Q000188:drug therapy* / Q000209:etiology; D018926:Anti-Allergic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002908:Chronic Disease; D006801:Humans; D012008:Recurrence; D014581:Urticaria / Q000188:drug therapy* / Q000209:etiology
D018926:Anti-Allergic Agents